| Product | Code | ||
|---|---|---|---|
| CCDC9 Antibody (N-term) | AP10786A | 400 µl |
Contact us |
| CR1L Antibody (C-term) | AP10787b | 400 µl |
Contact us |
| CWC22 Antibody (N-term) | AP10788a | 400 µl |
Contact us |
| DPEP3 Antibody (C-term) | AP10789b | 400 µl |
Contact us |
| ERMP1 Antibody (C-term) | AP10790b | 400 µl |
Contact us |
| F131C Antibody (N-term) | AP10791a | 400 µl |
Contact us |
| FA13C Antibody (C-term) | AP10792b | 400 µl |
Contact us |
| FA59A Antibody (Center) | AP10793c | 400 µl |
Contact us |
| GIMA7 Antibody (C-term) | AP10794b | 400 µl |
Contact us |
| LIX1 Antibody (C-term) | AP10795b | 400 µl |
Contact us |
| MCAR1 Antibody (N-term) | AP10796a | 400 µl |
Contact us |
| MTX2 Antibody (C-term) | AP10797b | 400 µl |
Contact us |
HansaBioMed: leader in exosome based solutions for Life Sciences HansaBioMed OU is an innovative Company performing research and development in the field of Exosome Sciences. Its mission is to consolidate and maintain the worldwide leadership in production and commercialization of kits, reagents, equipment and services dedicated to exosome research for the Life Science market. HansaBioMed develops, produces and commercializes a wide range of products dedicated to the expanding market of exosome research, which are essential tools for all scientists engaged in this rapidly growing field of science. The best known of HansaBioMed owned brands is the ExoTESTTMplatform, a proprietary immune-based solution to capture, quantify and characterize exosomes from biological fluids.